# JW Pharmaceutical

Organization · id `cardio:org-jw-pharmaceutical` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=JW+Pharmaceutical>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: JW Pharmaceutical
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia (`cardio:ct-nct01402843`)
- Sponsors: A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients (`cardio:ct-nct01529528`)
- Sponsors: Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone (`cardio:ct-nct01529541`)
- Sponsors: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (`cardio:ct-nct02056847`)
- Sponsors: To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension (`cardio:ct-nct05331014`)
- Sponsors: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus (`cardio:ct-nct05814393`)
- Sponsors: To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM (`cardio:ct-nct05814406`)
- Sponsors: Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia (`cardio:ct-nct06643130`)
- Sponsors: Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia (`cardio:ct-nct06955104`)
- Sponsors: Glycemic Variability of Combination Therapies in T2DM (`cardio:ct-nct07442006`)

## Provenance

Content hash: 194dcd8cde26196b20af1c59437461134c59b708e834b9b0f086778adeaf8ed5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
